GNA11 and basal cell carcinoma: Specific DEGs in non-CSCs cells showed enrichment in cancer-related pathways such as the cAMP signalling pathway (ADCY3, ORAI1, HTR1D and GLI1), basal cell carcinoma (WNT11 and GLI1), p53 signalling pathway (DDB2 and SFN) and pathways in cancer (ADCY3, GNA11, WNT11, BIRC3, and GLI1) (Figure 12).